Pedersen, Lars

Vagotomy and subsequent risk of Parkinson's disease

Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsVagus Nerve Stimulation Research

Cited by 806

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study

Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., Lidegaard, Ø., Tapia, G., Gulseth, H. L., Ruiz, P. L.-D., et al. (2021) · BMJ

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 401

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study

Ahern, T. P., Pedersen, L., Tarp, M., Cronin-Fenton, D. P., Garne, J. P., Silliman, R. A., Sorensen, H. T., & Lash, T. L. (2011) · JNCI Journal of the National Cancer Institute

Cancer, Lipids, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 387

Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case–Control Study

Robertson, D. J., Larsson, H., Friis, S., Pedersen, L., Baron, J. A., & Sørensen, H. T. (2007) · Gastroenterology

Inflammatory mediators and NSAID effectsColorectal Cancer Screening and Detection

Cited by 139

Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit/hyperactivity disorder in offspring

Christensen, J., Pedersen, L., Sun, Y., Dreier, J. W., Brikell, I., & Dalsgaard, S. (2019) · JAMA Network Open

Pharmacological Effects and Toxicity StudiesAttention Deficit Hyperactivity Disorder

Cited by 127

Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study

Thomsen, R. W., Pedersen, L., Møller, N., Kahlert, J., Beck-Nielsen, H., & Sørensen, H. T. (2015) · Diabetes Care

Pancreatitis Pathology and TreatmentDiabetes Treatment and Management

Cited by 89

Early glycemic control and magnitude of HbA1c reduction predict cardiovascular events and mortality: population-based cohort study of 24,752 metformin initiators

Svensson, E., Baggesen, L. M., Johnsen, S. P., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Thomsen, R. W. (2017) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 77

Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss

Mailhac, A., Pedersen, L., Pottegård, A., Søndergaard, J., Mogensen, T., Sørensen, H., & Thomsen, R. (2024) · Clinical Epidemiology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 60

Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study

Grønbæk, L., Vilstrup, H., Pedersen, L., Christensen, K., & Jepsen, P. (2018) · Journal of Hepatology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 50

Statin Use and Risk of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Sørensen, H. T., Riis, A. H., Lash, T. L., & Pedersen, L. (2010) · Circulation: Cardiovascular Quality and Outcomes

Amyotrophic Lateral Sclerosis ResearchLipoproteins and Cardiovascular Health

Cited by 43

Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes

Thomsen, R. W., Baggesen, L. M., Søgaard, M., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Johnsen, S. P. (2015) · Diabetologia

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 32

Hepatobiliary cancer risk in patients with inflammatory bowel disease: a scandinavian population-based cohort study

Erichsen, R., Olén, O., Sachs, M. C., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Ludvigsson, J. F., & Sørensen, H. T. (2021) · Cancer Epidemiology, Biomarkers & Prevention

Inflammatory Bowel DiseaseCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 31

Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes

Bonnesen, K., Heide-Jørgensen, U., Christensen, D. H., Christiansen, C. F., Lash, T. L., Hennessy, S., Matthews, A. A., Pedersen, L., Thomsen, R. W., & Schmidt, M. (2025) · JAMA Internal Medicine

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 17

Cohort Profile: Better Health in Late Life

Sørensen, H., Christensen, T., Bøtker, H. E., Christiansen, C., Fuglsang, C., Gribsholt, S., Kristensen, F., Laugesen, K., Laursen, A., Nørgaard, M., et al. (2023) · Clinical Epidemiology

Chronic Disease Management StrategiesPharmaceutical Practices and Patient Outcomes

Cited by 7

Discontinuation of Semaglutide Therapy for Obesity Management

Mailhac, A., Pedersen, L., Petersen, I., Pottegård, A., Sørensen, H. T., & Thomsen, R. W. (2026) · JAMA Network Open

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 1